4//SEC Filing
Bhatia Sangeeta N. 4
Accession 0001209191-23-052622
CIK 0000875320other
Filed
Oct 10, 8:00 PM ET
Accepted
Oct 11, 4:14 PM ET
Size
4.7 KB
Accession
0001209191-23-052622
Insider Transaction Report
Form 4
Bhatia Sangeeta N.
Director
Transactions
- Sale
Common Stock
2023-10-06$360.00/sh−242$87,120→ 4,144 total
Footnotes (1)
- [F1]Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/10/2023.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001643921
Filing Metadata
- Form type
- 4
- Filed
- Oct 10, 8:00 PM ET
- Accepted
- Oct 11, 4:14 PM ET
- Size
- 4.7 KB